ORGO
Organogenesis Holdings Inc
NASDAQ: ORGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.35
+2.17% today
Updated 2026-04-30
Market cap
$307.45M
P/E ratio
15.93
P/S ratio
0.55x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$2 – $7
Volume
1.4M
WallStSmart proprietary scores
67
out of 100
Grade: B
Buy
Investment rating
8.7
Growth
A5.0
Quality
C+6.5
Profitability
B7.7
Valuation
B+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$8.00
+240.43%
12-Month target
$2.86
+21.70%
Intrinsic (DCF)
$18.81
Margin of safety
+80.12%
0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $34.77M — positive
+ Revenue growth 78.10% QoQ
+ 80.12% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $450.89M | $433.14M | $482.04M | $564.17M | $564.17M |
| Net income | $15.53M | $4.95M | $861000.00 | $37.03M | $43.70M |
| EPS | — | — | — | — | $0.15 |
| Free cash flow | $-9.04M | $6.55M | $4.18M | $-24.46M | $34.77M |
| Profit margin | 3.44% | 1.14% | 0.18% | 6.56% | 6.56% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-09 | LEIBOWITZ, ARTHUR S | Buy | 5,000 | $2.68 |
| 2026-03-09 | DRISCOLL, MICHAEL JOSEPH | Buy | 10,000 | $2.67 |
| 2026-03-01 | CAVORSI, ROBERT | Sale | 700 | $3.21 |
Peer comparison
Smart narrative
Organogenesis Holdings Inc trades at $2.35. representing a P/E of 15.93x trailing earnings. Our Smart Value Score of 67/100 indicates the stock is good. TTM revenue stands at $564.17M. with profit margins at 6.56%. Our DCF model estimates intrinsic value at $18.81.
Frequently asked questions
What is Organogenesis Holdings Inc's stock price?
Organogenesis Holdings Inc (ORGO) trades at $2.35.
Is Organogenesis Holdings Inc overvalued?
Smart Value Score 67/100 (Grade B, Buy). DCF value $18.81.
What is the price target of Organogenesis Holdings Inc (ORGO)?
The analyst target price is $8.00, representing +240.4% upside from the current price of $2.35.
What is the intrinsic value of Organogenesis Holdings Inc (ORGO)?
Based on our DCF model, intrinsic value is $18.81, a +80.1% margin of safety versus $2.35.
What is Organogenesis Holdings Inc's revenue?
TTM revenue is $564.17M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.55x
ROE9.04%
Beta1.48
50D MA$2.76
200D MA$4.16
Shares out0.13B
Float0.06B
Short ratio—
Avg volume1.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—